XTRA:RDCConsumer Retailing
A Look At Redcare Pharmacy (XTRA:RDC) Valuation After Earnings Reveal Growth And Ongoing Margin Pressures
Why Redcare Pharmacy’s latest earnings moved the stock
Redcare Pharmacy (XTRA:RDC) shares reacted sharply after the company reported full year 2025 earnings, with higher sales of €2.94b, a narrower net loss of €37.7m, and fresh guidance for 2026.
The market response, including a 21.01% one day drop in the share price, reflected investor focus on margin pressures, mixed cash flow signals, and how the new growth targets might affect profitability.
See our latest analysis for Redcare...